NCT05277051 2026-03-23First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid TumorsGlaxoSmithKlinePhase 1 Active not recruiting152 enrolled
NCT05819892 2026-03-11Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial CancerM.D. Anderson Cancer CenterPhase 1 Recruiting21 enrolled
NCT03955978 2026-01-06TSR-042 in Addition to Standard of Care Definitive Radiation for Inoperable Endometrial CancerWashington University School of MedicinePhase 1 Active not recruiting10 enrolled